Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 4/20 | 0.58 |
| ▸ | GABRA2 | P47869 | 11/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 11/20 | 0.46 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.46 |
| ▸ | MLYCD | O95822 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21606685 | 0.89 | RORC (0.55) | RORCGABRA2GABRB2NR1H2MLYCD | |
| SCHEMBL21606465 | 0.84 | GABRA2 (0.49) | RORCGABRA2GABRB2MLYCDKDM4E | |
| SCHEMBL21606481 | 0.77 | RORC (0.55) | RORCGABRA2GABRB2KDM4E | |
| SCHEMBL24463874 | 0.74 | RORC (1.00) | RORC | |
| SCHEMBL24463792 | 0.74 | RORC (1.00) | RORC | |
| SCHEMBL21606440 | 0.74 | RORC (1.00) | RORC | |
| SCHEMBL21606483 | 0.72 | GABRA2 (0.52) | GABRA2GABRB2MLYCD | |
| SCHEMBL21606460 | 0.72 | GABRA2 (0.55) | GABRA2GABRB2NR1H2MLYCDKDM4E | |
| SCHEMBL25879955 | 0.71 | NR1H2 (0.65) | GABRA2GABRB2NR1H2MLYCDKDM4E | |
| SCHEMBL1425236 | 0.70 | CYP1A2 (0.46) | GABRA2GABRB2NR1H2KDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11345666-B2 | Phenyl and pyridinyl substituted imidazoles as modulators of RORγT | JANSSEN PHARMACEUTICA NV (BE) | 2022-05-31 | — | — | US | disclosed |
| WO-2019244000-A1 | PHENYL AND PYRIDINYL SUBSTITUTED IMIDAZOLES AS MODULATORS OF RORYT | JANSSEN PHARMACEUTICA NV (BE) | 2019-12-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11345666-B2 | Phenyl and pyridinyl substituted imidazoles as modulators of RORγT | RORC, RORB, RORA | RORC 1/4885GABRA2 1154/4885GABRB2 984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.